iBio, Inc.
IBIO
$4.57
-$0.2896-5.96%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -7.40% | -21.03% | -6.32% | -22.78% | -62.01% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.74% | -20.32% | -27.81% | -41.22% | -57.48% |
| Operating Income | 1.71% | 19.54% | 31.34% | 41.22% | 57.48% |
| Income Before Tax | 2.76% | 21.38% | 34.18% | 58.03% | 57.51% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 2.76% | 21.38% | 34.18% | 58.03% | 57.51% |
| Earnings from Discontinued Operations | -- | -- | -311.63% | 47.09% | 83.81% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 46.85% | 30.58% | -28.92% | 56.51% | 75.53% |
| EBIT | 1.71% | 19.54% | 31.34% | 41.22% | 57.48% |
| EBITDA | 0.89% | 19.60% | 32.67% | 43.23% | 58.78% |
| EPS Basic | 89.20% | 90.37% | 87.11% | 92.28% | 93.54% |
| Normalized Basic EPS | 80.24% | 89.09% | 93.42% | 89.56% | 88.78% |
| EPS Diluted | 89.20% | 90.37% | 87.11% | 92.28% | 93.54% |
| Normalized Diluted EPS | 80.24% | 89.09% | 93.42% | 89.56% | 88.78% |
| Average Basic Shares Outstanding | 392.03% | 620.62% | 900.35% | 463.43% | 278.78% |
| Average Diluted Shares Outstanding | 392.03% | 620.62% | 900.35% | 463.43% | 278.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
